AdvisorShares Investments LLC

Position in NRXP — NRX Pharmaceuticals, Inc.

CIK 1425930 BETHESDA, MD

Position in NRXP

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,695,383

+$1,799,789 QoQ

Shares Held

659,018

+56.7% QoQ

Ownership

1.52%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

of 47 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AdvisorShares Investments LLC holds $30,987,010 across 21 Biotechnology names. NRXP ranks #4 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	121,381	$5,709,762
2	ATAI	AtaiBeckley Inc.	882,892	$4,652,840
3	RLMD	Relmada Therapeutics, Inc.	438,901	$3,037,194
4	NRXP	NRX Pharmaceuticals, Inc. This page	659,018	$2,695,383
5	HELP	Cybin Inc.	292,711	$1,934,819
6	GHRS	GH Research PLC	71,267	$1,915,656
7	ANRO	Alto Neuroscience, Inc.	70,748	$1,867,039
8	DRUG	Bright Minds Biosciences Inc.	24,274	$1,704,034

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,695,383	659,018	+56.7%	Shares	Sole	2026-08-11
2026-03-31	$895,594	420,467	+28.2%	Shares	Sole	2026-04-28
2025-12-31	$888,890	328,004	-4.1%	Shares	Sole	2026-02-10
2025-09-30	$1,129,048	342,136	+29.7%	Shares	Sole	2025-11-05
2025-06-30	$859,978	263,797	-8.0%	Shares	Sole	2025-08-04
2025-03-31	$587,933	286,797	-7.6%	Shares	Sole	2025-05-13
2024-12-31	$682,690	310,314	+138.5%	Shares	Sole	2025-02-14
2024-09-30	$219,843	130,085	+20.4%	Shares	Sole	2024-11-14
2024-06-30	$263,727	108,085	-82.4%	Shares	Sole	2024-08-07
2024-03-31	$290,182	614,793	-4.3%	Shares	Sole	2024-05-14
2023-12-31	$295,610	642,632	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.